Skip to content

PhysSurg-B : Physical Activity in Relation to Surgical Operations - Breast Cancer

PhysSurg-B : Physical Activity in Relation to Surgical Operations, a Prospective Open-label Randomized Controlled Multicenter Study of the Effect of Physical Activity on Recovery After Breast Cancer Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02560662
Acronym
PhysSurg-B
Enrollment
400
Registered
2015-09-25
Start date
2016-01-27
Completion date
2020-02-11
Last updated
2024-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast cancer, physical exercise, recovery

Brief summary

The purpose of this study is to investigate whether a training program with intensified physical exercise prior to and after surgery for breast cancer enhances postoperative recovery.

Detailed description

This study is designed as a randomised, controlled, non-blinded multicenter trial with two parallell study groups, intervention and control. The primary endpoint of recovery is measured within 12 months after surgery. After randomisation, participants in the intervention group will be scheduled for an individual consultation with the physiotherapist, where the are advised to increase their Daily physical activiy level with an additional 30 minutes. The added physical activity is registered in an exercise diary daily. All included participants will be asked to complete questionnaires at inclusion (I), 4 weeks (+/- 1 w) postoperatively (II) and 12 months (+/-1 month) postoperatively (III). Data regarding patient characteristics, surgical details, postoperative events, complications according to Clavien - Dindo and additional treatment will be collected using eCRF: (I) 30 Days postoperatively, (II) 90 days postoperatively and (III) 12 months postoperatively. Data will also be retrieved from the Swedish National Breast Cancer Register, the Swedish Social Insurance Agency and the Swedish National Death Register. Patrticipants who wish to be excluded from the study will be asked if already collected data may be analysed in the study. The code for the study cohort will include personal identity as well as a study specific code. This is placed on a server, with limited access, at Sahlgrenska University Hospital. The database is placed on a server within the University of Gothenburg system accessible with username and code. The database includes only the study specific code for each participant. Data from questionnaires will be entered manually. Length of hospital stay will be acquired from the hospital registries and then entered manually into the database. Data from CRF (I-III) will be entered in the same database, as well as data retrieved from the Swedish National Breast Cancer Register, the National Death Register and Swedish Social Insurance Agency. In all a high security standard with automatic back up of server data is present as well as firewalls against external violation. A data manager, employed by the SSORG unit will be responsible for the database. The investigators plan to perform an interim analysis for the first 100 patients included, in order to make a more exact estimate of the power needed. An external monitoring committee will be appointed for the interim analysis, and the question to the committee will be limited to a recalculation of cohort size.The participants will be analysed according to randomisation (intention to treat-type of analysis).

Interventions

BEHAVIORALPhysical activity

Preoperative intervention - takes place from randomization until surgery (4 weeks +/-2 w): • 30 minutes of exercise daily added to the existing daily exercise routine. The level of exercise should produce shortness of breath but the patient should be able to talk without much effort. Postoperative intervention - takes place from discharge from the hospital until 4 weeks postoperatively: • 30 minutes of exercise daily added to the existing daily exercise routine. The level of exercise should produce shortness of breath but the patient should be able to talk without much effort. Participants randomized to intervention will receive a visit to a physiotherapist for personally adjusted information regarding the intervention, later followed up with a telephone call.

Sponsors

Vastra Gotaland Region
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* All female patients at the participating hospital scheduled for breast cancer surgery will be asked to participate.

Exclusion criteria

* Inability to understand given information. * Inability to perform the intervention, as assessed by the person performing inclusion. * Withdrawal of informed consent. * Male sex. * Stage IV breast cancer at diagnosis. * Neoadjuvant breast cancer treatment.

Design outcomes

Primary

MeasureTime frameDescription
Change in self-reported physical and psychological recoveryInclusion, 4 weeks (+/- 1 week) and 12 months (+/- 1 month) postoperativelyMeasured using validated questions within a questionnaire
Sick leave12 months postoperativelyData from the Swedish Social Insurance Agency (Försäkringskassan) on total number of days and the reasons (diagnosis) for any sick-leave episodes

Secondary

MeasureTime frameDescription
Re-operations and re-admittances12 months postoperativelyThe number of participants with re-admittances to hospital and/or re-operations after the index surgery will be retrieved from hospital registration systems and analyzed
Length of hospital stay30 days postoperativelyFor each participant the number of days of hospital stay for the index surgery will be collected
Health economy12 months postoperativelyAnalysis using modelling, focusing on the societal perspective and measuring the effects of regular physical exercise for resource consumption, measured in Swedish currency SEK.
Mortality3 and 5 years postoperativelyData retrieved from National Death Register, overall and cancer-specific mortality
Adverse events90 days postoperativelyClassified according to Clavien-Dindo

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026